Mirion Technologies Reports Strong Q4 & FY25 Results, Provides Robust FY26 Guidance
summarizeSummary
Mirion Technologies reported increased revenues and Adjusted EBITDA for Q4 and full year 2025, returning to GAAP net income profitability, and issued strong guidance for 2026, driven by record orders.
check_boxKey Events
-
Strong Q4 2025 Financial Performance
Revenues increased 9.1% to $277.4 million, GAAP net income improved 11.9% to $17.8 million, and Adjusted EBITDA rose 11.5% to $77.6 million compared to the prior year period.
-
Full Year 2025 Highlights
Total revenues reached $925.4 million, up from $860.8 million in 2024, and the company achieved a GAAP net income of $29.8 million, reversing a net loss of $36.6 million in 2024. Adjusted EBITDA for the full year was $227.9 million.
-
Robust Full Year 2026 Guidance
Mirion projects total revenue growth between 22.0% and 24.0%, organic revenue growth of 5.0% to 7.0%, Adjusted EBITDA between $285 million and $300 million, and Adjusted EPS of $0.50 to $0.57 per share.
-
Record Order Book
The company booked over $1 billion in orders in 2025, including approximately $150 million from a large opportunity pipeline, with growth across all three Nuclear Power verticals.
auto_awesomeAnalysis
Mirion Technologies, Inc. announced solid financial results for the fourth quarter and full year 2025, demonstrating significant growth in revenues and a return to GAAP net income profitability for the full year. The company also provided an optimistic outlook for fiscal year 2026, projecting substantial revenue and Adjusted EBITDA growth. The CEO highlighted record orders in 2025, including significant contributions from the nuclear power sector, and anticipates continued strong order growth in 2026. This positive performance and forward-looking guidance suggest a healthy operational trajectory and strong market tailwinds.
At the time of this filing, MIR was trading at $21.25 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $5.9B. The 52-week trading range was $12.00 to $30.28. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.